AM-101 in the Treatment of Acute Tinnitus 3

NCT02040194 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

893

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinnitus

Interventions

DRUG: AM-101
DRUG: Placebo

Sponsor

Auris Medical AG